Tuesday, May 5, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Innovations & Investing

AI and Medicine Don’t Mix

Medicine was never meant to be standardized

Jay K Joshi by Jay K Joshi
May 8, 2024
in Innovations & Investing
0
AI and Medicine Don't Mix

Planet Volumes

Artificial intelligence (AI) has revolutionized many industries,  including the healthcare system but when it comes to medicine, there is a fear that it may not work well due to patients’ aversion to standardized care and control from AI systems. However, the integration of AI in healthcare has the potential to greatly benefit patients and improve overall healthcare outcomes.

One of the primary concerns about AI in medicine is the fear of standardized care. Patients often prefer personalized treatment plans tailored to their specific needs and preferences. They fear that AI algorithms may lead to a one-size-fits-all approach that ignores the individuality of each patient. However, AI can actually enhance personalized medicine by analyzing vast amounts of data to identify patterns and trends that can inform more targeted and effective treatments. AI can help healthcare providers deliver more personalized and precise care that is tailored to each patient’s unique needs, showcasing innovations in healthcare.

Another concern is the perceived loss of control from AI systems in medicine. Patients may feel uncomfortable with the idea of AI making decisions about their healthcare without human oversight. However, AI can be used as a tool to assist healthcare providers in making more informed decisions, rather than replacing human judgment altogether. AI can analyze complex medical data, detect patterns, and offer recommendations to healthcare providers, but ultimately, the final decision lies with the human caregiver.

Incorporating AI in medicine can lead to more efficient and accurate diagnoses, improve treatment planning, and enhance patient outcomes. AI can help healthcare providers in diagnosing diseases at an early stage, predicting patient outcomes, and monitoring patients’ progress in real-time. By streamlining administrative tasks and reducing errors, AI can also help healthcare organizations save time and resources, allowing them to focus more on providing quality care to patients.

While there may be concerns about AI in medicine, the general consensus currently is that the benefits of integrating AI systems far outweigh the drawbacks. Patients can still receive personalized care and maintain control over their healthcare decisions, while leveraging the power of AI to improve overall healthcare delivery. It is essential for healthcare providers to work collaboratively with AI systems to ensure that patients receive the best possible care while maintaining a human touch in the healthcare experience, an important aspect of healthcare policy.

Yes, it is true that AI has the potential to revolutionize the field of medicine by improving diagnostic accuracy, treatment outcomes, and overall efficiency. However, along with its benefits, there are also significant risks associated with the use of AI in medicine. Rather than dismiss those risks, we should pay close attention to them and listen to patients when they express concerns around those risks.

One major risk of AI in medicine is the potential for errors or biases in the algorithms used to make medical decisions. AI systems rely on data to learn and make predictions, and if the data is biased or incomplete, it can lead to inaccurate diagnoses or treatment recommendations. Additionally, AI systems may not always be able to explain the reasoning behind their decisions, which can be concerning when it comes to matters of life and death.

Another risk of AI in medicine is the threat to patient privacy and data security. Medical data is highly sensitive and confidential, and the use of AI systems to analyze this data raises concerns about who has access to it and how it is being used. Unauthorized access or misuse of this data could have serious consequences for patients and healthcare providers.

There is a fear among patients about the loss of the human touch in healthcare. Many patients value the personal connection they have with their healthcare providers and may be hesitant to trust AI systems with their care. Patients may also be concerned about the lack of empathy and understanding that AI systems can provide compared to a human healthcare provider.

Overall, these risks contribute to the reluctance of patients to adopt AI in medicine. Despite the potential benefits of AI, patients may be hesitant to fully embrace this technology until these risks are addressed and mitigated. Healthcare providers and policymakers must carefully consider these risks and work towards building trust and transparency in the use of AI in medicine to ensure its successful adoption.

Ultimately, the adoption of AI will not take place broadly nor at a systemic level. Rather, it will be adopted on a case by case basis specific to the patients’ needs. AI will not standardized medicine nor make it more efficient as a whole. It will make specific processes and procedures more effective than before.

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Joshi is the founding editor of Daily Remedy.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • Detecting Hospital M&A Synergies Before They’re Announced: A Rate-Based Event Strategy

    Detecting Hospital M&A Synergies Before They’re Announced: A Rate-Based Event Strategy

    0 shares
    Share 0 Tweet 0
  • The ASC Rate Arbitrage: How Ambulatory Surgery Center Growth Looks in Procedure-Level Price Data

    0 shares
    Share 0 Tweet 0
  • A Two Headed Monster – State Attorneys General and the Drug Enforcement Agency

    3 shares
    Share 0 Tweet 0
  • Conspiracy to Convict the Innocent

    0 shares
    Share 0 Tweet 0
  • Nonlinear Healthcare Models

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy